Biobased industrial products: Back to the future for agriculture by Zeikus, J. Gregory
In 2000, the National Research Council published a report on the potential
impact of biobased industrial products in the twenty-first century. The priorities
for research and commercialization were described in terms of agriculture
expanding into health, energy, chemicals and materials. Agriculture is now
armed with new biotechnology and bioprocessing tools, and is going back
to reclaim the markets it lost to the petrochemical industry after the 1930s.
This paper will discuss new markets and research and development priorities,
and provide examples of new biobased industrial products that are entering
commercialization. These include transgenic plants, pharmaceuticals,
biochemicals, fuels, agri-chemicals, bioplastics, and higher-value polymers
and materials. As an example, the role of MBI International in the scale-up
and demonstration of these new biobased industrial product technologies will
be highlighted.
INTRODUCTION
The NRC report, Biobased Industrial Products, assumes that “biological sciences
will have the same impact on the formation of new industries in the next
century as physical and chemical sciences have had on industrial development
in this century” (NRC 2000). This prediction is supported in part by four
dominant themes. First, US agriculture’s history of making industrial products
from agricultural feedstock before the advent of the petrochemical industry, and
the realization that agricultural carbohydrates are a lower-cost resource than
petroleum-based hydrocarbons (Figure 1). Before 1940, medicines, synthetic
fibers, plastics, paints and inks were made from agricultural feedstock. For
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example, in 1935, each Ford car contained components manufactured from
two pounds of soybeans. Second, the new tools of genetic and bioprocess
engineering now enable economic improvements in feedstock utility and
manufacturing systems. They produce a wider diversity of higher-value
products than is feasible by petrochemical processing. Third, significant
environmental problems, including pollution and global warming, are
associated with industrial processing of fossil fuels. Finally, it is common
sense that petroleum, a non-renewable chemical and energy resource needs
to be replaced by renewable agricultural carbohydrates to drive the economy
of the new millennium.
These factors invite the question, “Are biobased industries America’s next
frontier?” If so, there is need for a national awareness far greater than that used
to launch the space program that put the first man on the moon. Both our
future economic and our planetary well being are at stake in developing the
“Biobased Industrial Products Society.” In the rest of this discourse, I will
address market-pull and technology-push issues, the NRC report, research and
commercialization priorities, and the role of universities, federal laboratories,
MBI International and others in making this vision of the future a reality.
MARKET PULL–TECHNOLOGY PUSH
A wide variety of industrial products, including biomaterials, fuels, and
biochemicals are already manufactured from biobased raw materials (Figure 2).
Figure 1. Cost of raw materials: fossil vs. renewable plant materials
(NRC 2000).
TABLE 1. TARGETS FOR A NATIONAL BIOBASED INDUSTRY
(NRC 2000)
Biobased production levels
(percent derived from biobased feedstocks)
Biobased product Current level Future target: Future target:
intermediate (2020) ultimate (2090)
Liquid fuels 1–2% 10% Up to 50%
Organic chemicals 10% 25% 90+%
Materials 90% 95% 99%
The current emphasis placed on production of liquid fuels (i.e. ethanol) is
a difficult challenge because it competes with a petroleum product, gasoline,
which requires minimal refining. Oxychemicals, on the other hand, offer the
possibility to produce higher value organic molecules via biobased processes,
because costs to introduce oxygen into hydrocarbons are higher for oil refining.
The NRC report targets for increasing biobased industrial products manufac-
tured in the US over current levels for liquid fuels, organic chemicals and
materials are 50 percent, 90 percent and 99 percent, respectively, of total
industrial production by 2090 (Table 1).
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Figure 2. Biobased products manufactured today (NRC 2000).
Soybean Oils and Inks
Pigments and Dyes
Paints and Varnishes
Soaps and Detergents
Industrial Adhesives
Biopolymers and Films
Composite Materials
Energy Fuels
Renewable Resources
Biomaterials Biochemicals
Coke
Lignin
Bagase
Fuel Oil
Ethanol
Methanol
Syngas
Methane
Hydrogen
Activated Carbon
Oxy-Fuel Additives
Phenols and Furfural
Specialty Chemicals
Acetic and Fatty Acids
Industrial Surfactants
Agricultural Chemicals
Solid Liquid Gaseous
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Industrial products are already made in large amounts from processed
agricultural carbohydrates (Zeikus 1990). Sales of these products increased
from $5,400 million in 1983 to $11,000 million in 1994 (Table 2). Sales of
specialty biochemical products (phytoceuticals, nutraceuticals, biocontrol
agents, vitamins, food-ingredient agents, etc.) are growing at greater than
15 percent annually. Crop processing has many added economic benefits for
the US when compared to petroleum processing (Table 3), including decreased
oil imports, enhanced balance of trade, decreased environmental pollution,
and the development of renewable sources of chemicals, fuels and materials.
TABLE 3. BENEFITS OF CROP PROCESSING TO INDUSTRIAL PRODUCTS
Better use of agricultural resources
Revitalize rural communities
Functionally superior products
Reduced dependence on foreign oil
Export more value-added industrial products vs. crop commodities
Potential greenhouse gas benefits
TABLE 2. WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS,
1983 AND 1994 (NRC 2000)
1983 1994
($ millions) ($ millions)
Fuel and industrial ethanol 800 1,500
High-fructose syrups 1,600 3,100
Citric acid 500 900
Monosodium glutamate 600 800
Lysine 200 700
Enzymes 400 1,000
Specialty chemicals 1,300 3,000
Total 5,400 11,000
Today, many new kinds of genetically engineered crops are entering the
marketplace. They lack approval in foreign markets and from the US public
because they are being viewed as “altered and unsafe.” This false perception is
not currently a problem in the marketplace for biobased industrial products.
For example, enzyme products from genetic engineering are already used in
making cheese and high-fructose corn syrup. Genetically engineered plants
for pharmaceutical synthesis are viewed as positive for lowering costs of drug
production. It is anticipated that genetic engineering of plants and microbes
will lower costs for both the feedstock and the manufacturing process for
biobased industrial products.
RESEARCH PRIORITIES
Decades of agronomic research have shown us how to inexpensively grow
crop commodities. Now, investment is needed to learn how to inexpensively
convert value-added crop commodities to industrial products. The NRC report
established research priorities for systems, biology, engineering, and research.
Research priorities for systems include:
• evaluate sustainability/environmental issues
• integrate biological and engineering research
• emphasize risk reduction/proof of concept
• develop infrastructure of trained people, databases, demonstration
facilities, etc.
• consider incentives/preferences.
Research priorities for biology include:
• the genetics of plants and bacteria that will improve understanding of
cellular processes and plant traits
• the physiology and biochemistry of plants and microorganisms directed
toward modification of plant metabolism and improved bioconversion
processes
• protein engineering methods to allow the design of new biocatalysts and
novel materials for the biobased industry
• maximization of biomass production.
Research priorities for engineering include:
• principles and processing equipment to handle solid feedstock
• fermentation technology to improve the rate of fermentation yield and
concentration of biobased products
• downstream technologies to separate and purify products in dilute aqueous
streams.
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MBI INTERNATIONAL
MBI is an entrepreneurial center that develops new industrial products made
from agricultural resources. MBI’s sole focus is on the risk reduction/proof
of concept stages of research and development. We call this “Death Valley”
because many new discoveries do not meet the objectives that are required for
commercialization. Negligible funds are available from industry and investors
to develop products from discoveries unless technical and economic validations
are presented (Figure 3). Since 1992, MBI has launched eleven technologies
into new biobased companies via our business pipeline model (Figure 4).
MBI (a non-profit 501c3 corporation) researches technologies and markets
for new inventions, and performs scale-up and economic demonstrations.
The commercial-ready technology is then transferred to Grand River Technolo-
gies, Inc. (MBI’s wholly owned for-profit subsidiary), for commercialization
via a start-up company, joint venture or warranted out-license.
Figure 3. Death Valley
Figure 4. MBI International
Lactech, Inc. was a joint venture with Cargill to develop low-cost polymer-
grade lactic acid by fermentation of corn glucose. At the completion of the
scale-up/demonstration phase, Lactech was fully acquired by Cargill, who then
formed a joint venture with Dow Chemical, Cargill Dow Polymers, LLC. This
new joint venture has invested $300 million in the first of three plants. Cargill
Dow plans to sell 3 billion pounds of polylactic acid in industrial fibers and
1.5 billion pounds in packaging plastic films, coatings and containers. The
first plant in Blair, Nebraska will use 40,000 bushels of corn per day.
Synthon Corporation of Princeton, NJ, is a second company launched by
MBI/GRT. It makes chiral intermediates from optically pure sugars, for drug
manufacture. The first technology used lactose, a by-product of cheese making,
to synthesize hydroxygamma butyl lactone, a compound used in $5 billion
worth of drugs including cholesterol depressants, analgesics, broad-spectrum
antibiotics and HIV protease inhibitors.
Auxein Corporation of Lansing, MI, is a third company launched by MBI/
GRT. It produces natural “plant metabolic primers” (i.e. γ-amino butyrate,
succinic acid, and glutamate) that enhance plant growth and decrease pesticide
usage under environmentally stressed growing conditions. This product
increases the yield of all crops, but most noticeably increases flowering, the size
of potatoes, Brix content of grapes and the solids content of tomatoes.
MBI has a full pipeline of biobased industrial product technologies currently
at various stages of proof-of-concept, scale-up and economic demonstration
(Table 4). One platform technology under development is succinic acid, which
promises to be a large-volume product (Zeikus et al. 1999). The reason ethanol
production from biomass is not economical without a subsidy is the loss of
carbon in current corn-processing systems. Notably, 2 moles of CO
2
 are lost
per mole of glucose fermented into two moles of ethanol. In the dry milling
process, non-fermented fiber is used as an even lower-value animal feed
TABLE 4. MBI’S CURRENT BIOBASED INDUSTRIAL PRODUCT
R&D PROJECTS
Coatings for medical devices
Coatings to prevent biofouling
Coatings for use in electronic devices
Low-cost, premium animal feeds
Oral vaccine production and delivery systems
Phytoceuticals
Biorepellents / biocontrol agents
Bioabrasives
High-value co-products from ethanol production
(including succinate and derivatives)
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byproduct in lieu of direct conversion to ethanol or higher-value products.
Succinic acid can be made by fermentation of a variety of carbohydrates,
including starch, cellulose, glucose and xylose. The succinic acid fermentation
fixes CO
2
, hence it can be integrated into ethanol fermentation to convert
both CO
2
 and cellulose fiber wastes into ethanol, thus improving the overall
product value and economics. Succinic acid can be utilized as an intermediary
carbon feedstock to make nylon, polyesters, engineered plastics and other
commercial solvents and chemicals (Figure 5).
CONCLUSION
The NRC report on biobased industrial products provides a roadmap for
research and commercialization policy needed for agriculture to go back to
the future and reclaim its higher-value industrial product markets. The market-
pull and technology-push dynamics are poised for this, and the US desperately
needs to reclaim control of its agricultural, chemical and energy economies as
well as enhance overall environmental quality for the future.
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